<p>John Johnson, Director, reported a disposal of common shares of Xeris Biopharma Holdings Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001410781-25-000006), on December 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

XERS

<p>John Johnson, Director of Xeris Biopharma Holdings Inc., reported the sale of common shares. The full filing is available via EDGAR, the U.S. SEC's system. This AI-generated news is for informational purposes only and not financial advice.</p>

Director John Johnson Reports Sale of Xeris Biopharma Holdings Inc. Common Shares